Association of anticardiolipin antibodies levels with instent restenosis in patients with coronary artery disease

Indian Journal of Physiology and Pharmacology

Volumn 52, Issue 3, 2008, Pages 288-292

  Sharma, Sumali ^a   Malhotra, Anita ^a   Sharma, Y P ^b   Pandhi, P ^b   Malhotra, Samir ^b   Sri Nageswari, K ^a   Shafiq, Nusrat ^b   Venkateshan, S P ^a   Kaur, Ravnit ^a  

^a GOVERNMENT MEDICAL COLLEGE AND HOSPITAL   (India)

^b POSTGRADUATE INSTITUTE OF MEDICAL EDUCATION AND RESEARCH   (India)

Author keywords

Anticardiolepin antibody; Coronary artery disease; Instent restinosis; Patients

Indexed keywords

CARDIOLIPIN ANTIBODY; IMMUNOGLOBULIN G;

ARTICLE; BLOOD; CASE CONTROL STUDY; CORONARY ARTERY DISEASE; FEMALE; GRAFT OCCLUSION; HUMAN; IMMUNOLOGY; MALE; MIDDLE AGED; STENT;

ANTIBODIES, ANTICARDIOLIPIN; CASE-CONTROL STUDIES; CORONARY ARTERY DISEASE; FEMALE; GRAFT OCCLUSION, VASCULAR; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; STENTS;

EID: 67651165134     PISSN: 00195499     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (10)

1. Liu MW, Voorhee WD 3rd, Agrawal S, Dean LS, Roubin GS. Stratification of the risk of thrombosis after intra coronary stenting for threatened or acute closure complication coronary balloon angioplasty: A Cook registry study. Am Heart J 1995; 130(1): 8-13.
2. Zennett MR. In-stent Stenosis: Pathology and implications for the development of drug eluting stents. Heart 2003; 89: 218-224.
3. Morton KE, Krilis SA, Baron DW, et al. Coronary artery bypass graft failure: an autoimmune phenomenon. Lancet 1986; 2: 1353-1357.
4. Sletness KE, Smith P, Abdelnoor M, et al. Antiphospholipid antibodies after myocardial infarction and their relation to mortality reinfarction and non-haemorrhagic stroke. Lancet 1992; 339: 451-453.
5. Harris EM, Gharavi AE, Hughes GR. Antiphospholipid antibodies. Clin Rheum Dis 1985; 11: 591-609.
6. Gurlek A, Ozdol C, Pamir G, Dincer J, Tutkak H, Oral D. Association between anticardiolipin antibodies and recurrent cardiac events in patients with acute coronary syndrome. Int Heart J 2005; 46: 631-638.
7. Roubin GS, Robinson KA, King SB, et al. Early and late results of intracoronary arterial stenting after coronary angioplasty in dogs. Circulation 7987: 76: 891.
8. Eber B, Kronberger-Schaffer E, Brussee H, Klima G, Obernosterer A, Toporsch M, Dusleag J, Klien W. Anticardiolipin antibodies are no marker for survival myocardial infarction. 1990; 68: 594-596.
9. Glueek CJ, et al. Evidence that anticardiolipin antibodies are independent risk factors for atherosclerotic vascular disease. Am J Cardiol 1999; 83: 1490-1494.
10. Zuckerman Eli, Shiran Avinoam, Sabo Edumund, Shmuel Zehava, et al. Anticardiolipin Antibodies in Non-Systemic Lupus Erythmatosus Patients: A controlled prospective study. Am J Med 1996; 171: 381-386.